Takeda to Sponsor The LaSalle Bank Chicago Marathon.Tokyo and Deerfield, Ill., Oct 12, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) Newswire) - Takeda Pharmaceutical Company Takeda Pharmaceutical Company Limited (武田薬品工業株式会社 Limited, Osaka, Japan ("Takeda") and its wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. , Takeda Pharmaceuticals North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. , Inc., Deerfield, Ill. ("TPNA TPNA Takeda Pharmaceuticals North America, Inc. ") announced today their official sponsorship of The LaSalle Bank LaSalle Bank Corporation is the holding company for LaSalle Bank N.A. and LaSalle Bank Midwest N.A. With $116 billion in assets, it is headquartered at 135 South LaSalle Street in Chicago, Illinois. Chicago Marathon The LaSalle Bank Chicago Marathon is a major marathon held yearly in Chicago in Cook County, Illinois, United States. Alongside the Boston, New York, London and Berlin Marathons, it is one of the five World Marathon Majors. , which will expand Takeda's commitment to endurance sports across the globe. A first-year sponsor of the Chicago race, Takeda has a history of marathon sponsorship in Japan. Takeda is an R&D-driven company, striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products with emphasis in lifestyle-related diseases, oncology and urologic diseases, central nervous system diseases and gastroenterology gastroenterology Medical specialty dealing with digestion and the digestive system. In the 17th century Jan Baptista van Helmont conducted the first scientific studies in the field; William Beaumont published his own observations in 1833. diseases. "Takeda, a company with 225 years of pharmaceutical excellence, understands perseverance," said Kunio Takeda, chairman of Takeda Pharmaceutical Company Limited."We are proud to support the thousands of runners who are committed to crossing the finish line, just as we strive to create superior pharmaceutical products." Recognizing the importance of being an active member of the community, Takeda pledges a commitment to do so in its company philosophy - "contributing to society by providing medicine through integrity in corporate activities." "We commend all marathon participants and are honored to play a part as they achieve their goals in this city where many of our employees work and live," said Mark Booth, president of Takeda Pharmaceuticals North America. "We are especially proud of our Team Takeda employees who will be running with the more than 40,000 other marathon participants." Growing from three to approximately 3,000 employees in eight years, Takeda will celebrate the grand opening of the new home office for Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. in Deerfield, Ill., on Oct. 20. About Takeda Pharmaceutical Takeda Pharmaceutical, located in Osaka, Japan, is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available through its corporate website, http://www.takeda.com/index-e.html. Source: Takeda Pharmaceutical Contact: Takeda Pharmaceutical Company Limited Corporate Communications Tel: +81-6-6204-2060 Fax: +81-3-3278-2039 http://www.takeda.co.jp Copyright [c] 2006 JCN Newswire. All rights reserved. A division of Japan Corporate News Network K.K. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion